LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it will present at the LD Micro Conference on Thursday December 3, 2009 at 11:30am PST the Luxe Hotel in Los Angeles. Manish Singh, Ph.D., President and CEO of the Company, will present a corporate overview in addition to providing a clinical update highlighting some of the positive results that the Company’s innovative portfolio of cancer immunotherapies have displayed in recent clinical trials, including results from Phase I testing in ICT-107 which was demonstrated to significantly increase life expectancy in patients with glioblastoma compared to the current standard of care.
